20/20 Biolabs, Inc. (AIDX)

20/20 Biolabs Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	10.69	0.56	0.29
Debt / EBITDA Ratio	-0.32	-0.15	-0.19
Debt / FCF Ratio	-0.60	-0.32	-0.27
Net Debt / Equity Ratio	0.14	-0.63	-0.67
Net Debt / EBITDA Ratio	0.00	0.17	0.45
Net Debt / FCF Ratio	-0.01	0.36	0.63
Quick Ratio	0.64	1.42	4.11
Return on Equity (ROE)	-3393.17%	-368.76%	-149.07%
Return on Assets (ROA)	-	-154.88%	-100.37%
Return on Invested Capital (ROIC)	-2980.69%	-570.15%	-459.31%
Return on Capital Employed (ROCE)	190.22%	-252.03%	-122.71%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).